Publication: 85

Publication: 85

Low-Dose, Single-Agent Temsirolimus for Relapsed Mantle Cell Lymphoma

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Cancer vol 113 (3) 508-514

Year:: 2008
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10 CA035267, CA112904, CA97274, CA-35090, U10 CA060276, CA-35195, U10 CA037404, U10 CA035448, U10 CA063848, U10 CA035195, CA-25224, CA-37403, CA-35431, CA-60276, CA-35113, U10 CA035101, U10 CA035113, P30 CA015083, CA-63848, U10 CA035415, CA-63826, R21 CA112904, CA-35415, P50 CA097274, CA-35448, CA-35101, U10 CA025224, U10 CA035090, CA-15083, CA-35267, N01 CA015083

Corr. Author:
Authors:: Stephen M. Ansell David J. Inwards Kendrith M. Rowland Jr. Patrick J. Flynn Roscoe F. Morton Dennis F. Moore Scott H. Kaufmann Irene Ghobrial Paul J. Kurtin Matthew Maurer Christine Allmer Thomas E. Witzig

Networks:

Study: NCCTG-N0186
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: mantle cell lymphoma, temsirolimus, CCI-779, rapamycin, mammalian target of rapamycin kinase